Nicotine and Atherosclerosis

  • H. Schievelbein
  • G. Heinemann
Conference paper


Since the 1964 Surgeon General’s Beport, many epidemiological investigations have confirmed that, besides high blood cholesterol and hypertension, cigarette smoking is a main risk factor for the development of coronary heart disease (CHD) (1). Cigarette smoke consists of a mixture of thousands of different compounds, among which nicotine is regarded as the most pharmacologically-active component (2). The pharmacologic and toxicologic effects of nicotine are well-known, and should only be mentioned briefly. The main pharmacological action of nicotine is its stimulation of sympathetic ganglia and of the adrenal medulla, resulting in the release of catecholamines from sympathetic nerves and chromaffine tissues in different organs, thereby influencing fat metabolism, carbohydrate metabolism, thrombocytes, and blood coagulation (3). Furthermore, nicotine is known to release antidiuretic hormone from the pituitary (4) and to increase corticosteroid secretion (5). In higher doses of nicotine, stimulation is followed by paralysis of the central and peripheral nervous system and rapid death (6).


Smokeless Tobacco Tobacco User High Blood Cholesterol Serum Cotinine Chewing Tobacco 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The Health Consequences of Smoking (1979) U.S. Department of Health and Welfare, WashingtonGoogle Scholar
  2. 2.
    Wynder EL, Hoffmann D, Gori GB (1975) Smoking and Health. Proceedings of the 3rd World Conference. Modifying th.e Risk for the Smoker. DHEW Publ. No. (NIH) 76–1221Google Scholar
  3. 3.
    Schievelbein H (1977) The evidence for nicotine as an etiological factor in cardiovascular disease (CVD). In: Schettler G, Goto Y, Hata Y, Klose G (eds) Atherosclerosis IV, Springer Verlag Berlin-Heidelberg-New York, p 167Google Scholar
  4. 4.
    Burn HH, Truelove LH, Brun J (1945) The antidiuretic action of nicotine and of smoking. Brit Med J 1: 403–406PubMedCrossRefGoogle Scholar
  5. 5.
    Kershbaum A, Pappajohn DL, Bellet S, Hirabayaschi M, Shafiha H (1968) Effect of smoking and nicotine on adrenocortical secretion. J Amer Med Assoc 203: 275–277CrossRefGoogle Scholar
  6. 6.
    Petty PA (1963) Industrial Hygiene and Toxicology, Vol. 2. In: Passett DW, Irish DD (eds) Toxicology. Interscience Publishers New YorkGoogle Scholar
  7. 7.
    Mehta P, Mehta J (1981) Effect of smoking and nicotine on platelet - endothelial cell activity. In: Mehta J, Mehta P (eds) Platelets and Prostaglandins in Cardiovascular Disease, Futura Publishing Company, p 289Google Scholar
  8. 8.
    Saba SR, Mason RG (1975) Some effects of nicotine on platelets. Thromb Res 7: 819–822PubMedCrossRefGoogle Scholar
  9. 9.
    Handley AJ, Teather D (1974) Influence of smoking on deep vein thrombosis after myocardial infarction. Brit Med J 3: 230–231PubMedCrossRefGoogle Scholar
  10. 10.
    Marks P, Emerson PA (1974) Increased incidence of deep vein thrombosis after myocardial infarction in non-smokers. Brit Med J 3: 232–234PubMedCrossRefGoogle Scholar
  11. 11.
    Clayton JK, Anderson JA, McNicol GP (1978) Effect of cigarette smoking on subsequent postoperative thromboembolic disease in gynaecological patients. Brit Med J 2: 402PubMedCrossRefGoogle Scholar
  12. 12.
    Augustin J, Beedgen B, Spohr U, Winkel P (1982) The influence of smoking on the plasmalipoproteins. Innere Med 9: 104–106Google Scholar
  13. 13.
    Levine PH (1973) An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 48: 619–620PubMedGoogle Scholar
  14. 14.
    Bellet S, Deguzman NT, Kostis JB, Roman L, Fleischmann D (1972) The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Amer Heart J 83: 67–68PubMedCrossRefGoogle Scholar
  15. 15.
    Greenspan K, Edmands EB, Knoebel SB, Pish C (1969) Some effects of nicotine on cardiac automaticity, conduction, and ino- trophy. Arch Inter Med 123: 707–709CrossRefGoogle Scholar
  16. 16.
    Schievelbein H, Londong V, Londong W, Grumbach H, Remplik V, Schauer A, Immich H (1970) Nicotine and arteriosclerosis. Z Klin Chem Klin Biochem 8: 190–196PubMedGoogle Scholar
  17. 17.
    Fisher ER, Rothstein R, Wholey HH, Nelson R (1973) Influence of nicotine on experimental atherosclerosis and its determinants.Arch Path 96: 298–301PubMedGoogle Scholar
  18. 18.
    Liu LB, Taylor CB, Peng SK, Hikkelson B (1979) Experimental atherosclerosis in Rhesus monkeys induced by multiple risk factors: cholesterol, vitamin D, and nicotine. Arterial Wall v: 25–30Google Scholar
  19. 19.
    Wald NJ, Idle M, Boreham J, Bailey A, Van Vunakis H (1981) Serum cotinine levels in pipe smokers: evidence against nicotine as cause of coronary heart disease. The Lancet 2: 775–777 Google Scholar
  20. 20.
    Russell HAH, Jarvis HJ, Devitt G, Feyerabend C (1981) Nicotine intake by snuff users. Brit Hed J 283: 814–818CrossRefGoogle Scholar
  21. 21.
    Gritz ER, Baer-Weiss V, Benowitz NL, Yan Vunakis H, Jarvik HE (1981) Plasma nicotine and cotinine concentration in habitual smokeless tobacco users. Clin Pharmacol Therap 30: 201–204CrossRefGoogle Scholar
  22. 22.
    Vecht RJ, Graham GWS, Sever PS (1978) Plasma noradrenaline concentrations during isomeric exercise. Brit Heart J 40: 1216–1217 PubMedCrossRefGoogle Scholar
  23. 23.
    Danner SA, Endert E, Koster RW, Dunning AJ (1981) Biochemical and circulatory parameters during purely mental stress. Acta Hed Scand 209: 305–308CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • H. Schievelbein
  • G. Heinemann

There are no affiliations available

Personalised recommendations